Author

Inderpal Singh

Primary ORCID profile (0000-0002-7577-4161 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Inderpal SinghiD1 paper · Shri Mata Vaishno Devi University

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

Raj Reddy· 1 shared

Activity by Year

2024-2024 · peak 1/yr

1 paper

Recent·Most cited

CCT-217: A Landmark Gene Silencing Therapeutic for Weight Loss That Enhances Lean Mass Composition, Reduces Visceral, Subcutaneous Fat and Restores Metabolic Health in Obesity through Browning

Raj Reddy, Inderpal Singh

CCT-217, an siRNA therapy targeting CB1R and ZFP423, reduces body weight and visceral fat while preserving lean mass and improving metabolic health in obese mice.

bioRxiv · Dec 30, 2024 · PreprintPharmacology & Toxicology